Lilly’s Orforglipron Shows Significant Weight Loss in Phase 3 Trial Orforglipron can offer a new oral option for managing weight loss and blood sugar in type 2 diabetes treatment. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
